News Dec 23, 2018

Traphaco was honored with Top 10 Vietnam Gold Stars in two consecutively year

On December 23rd, 2018, the Central Committee of Vietnam Young Entrepreneurs Association celebrated the 15th Anniversary and awarded Vietnam Gold Star Award in 2018. Overcoming 400 selected and nominated brands from the top Provinces and Cities all over the country, Traphaco Joint Stock Company (Traphaco) was honored to be the sole representative of the pharmaceutical industry to be in the Top 10 Vietnamese Gold Stars in 2018.

In 2018, Vietnam Gold Star Award marks the 15-yearjourney of implementing and bringing out positive social values ​​and honoring the development of Vietnamese business community to contribute to the country's development. With the strict selection process, 40 evaluation teams are directly leaders of prestigious business leaders, experts in the fields of industry, accounting, accounting, KPMG auditing experts and presscommunication representatives... to verify the honesty and actual business operations of the companies.

Mr. Vuong Dinh Hue - Deputy Prime Minister and Mrs. Truong Thi Mai - Secretary of the Party Central Committee, Head of the Central Commission for Public Affairs awarded the prize of Top 10 Vietnamese Gold Star Enterprises to Mr. Tran Tuc Ma - General Director of Traphaco Joint Stock Company

The Top 10 Vietnam Gold Star Award 2018 is the recognition for Traphaco's efforts and achievements during 46 years for the destiny of caring for every people's health. ThroughoutTraphaco's journey, sustainable development is a strategy that is consistently implemented, covering all the Company's space and time. Traphaco always aims to develop green economy with 3 objectives: high economic efficiency associated with social responsibility and environmental protection; These three goals have created the success of Traphaco, forming the value chain of enterprises that are GACP-WHO standards of material areas - modern technology factories and extensive distribution system.

Traphaco was honored for the second time to be honored with Top 10 Vietnam Gold Stars

Affirming the No. 1 position in Oriental Medicine Industry, pioneering activities to develop pharmaceuticals from high quality medicinal herbs, Traphaco has developed a sustainable pharmaceutical development model. The company has the finest quality of growing areas for 5 medicinal plants (Polyscias Fruticosa, Glinus Oppositifolius, Artichoke, Ipomoea Nil and Ampelopsis Cantoniensis), granted by the Ministry of Health with GACP-WHO certificate.

Traphaco is the first pharmaceutical company to implement sales policy based on the principle of mutual benefit and pricecontrol. At the same time, the company applied DMS software in the management of distribution system including 1 distribution subsidiary, 28 branches, 40 agents nationwide; assist in directlyapproaching and caring for over 27,000 retail pharmacies.

In 2017, Traphaco's new pharmaceutical factory came into operation. With an area of ​​46,288m2 and a capacity of 1,200 million units of products / year, the factory is invested and applies smart pharmaceutical technologies 4.0, which are environmentally friendly, enabling online monitoring and controling of production processes. Being evaluated as the most modern factory in Vietnam pharmaceutical industry, the inauguration of Traphaco's modern westernmedicine factory was honored to be voted TOP 10 Outstanding Science and Technology Events in 2017.

In addition to the achievements of production and business activities, Traphaco also builds a professional and effective working environment, ensuring the salary, benefits and welfare of employees to grow steadily. Above from that, as a listed company in the stock market exchange, Traphaco also ensures the interests of shareholders as well as customers who are loyal with the Company.

Vietnam Gold Star Award will be the motivation for Traphaco to continue to be consistent with the strategy of "The Way of Green Health", aiming to become the number 1 pharmaceutical enterprise in terms of revenue, profit and market capitalizatino growth by 2020; to ceaselessly dedicate "green" products to be consistent with the modern society that determine Vietnamese medicine products are for Vietnamese people.